|
Office Locations:
|
235 Montgomery St., #1230
San Francisco, CA 94104
Phone: 415-392-7442
Fax: 415-392-4264
| | |
|
|
|
Life Sciences & Healthcare
|
|
|
Aberdare Ventures invests in early-stage healthcare opportunities. The firm is willing to participate in financings as small as $1 million and up to $15 million over time. The firm typically invests in companies near its San Francisco headquarters, but will however, invest alongside experienced investors in companies located elsewhere in and outside the U.S. Aberdare has more than $400 million of committed capital under management.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|